Expression of bone morphogenetic protein receptors type-IA, -IB, and -II correlates with tumor grade in human prostate cancer tissues

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2840-2844

  Kim, Isaac Yi ^a   Lee, Dong Hyeon ^a   Ahn, Han Jong ^b   Tokunaga, Hideo ^a   Song, Weitao ^a   Devereaux, Lisa M ^a   Jin, Donald ^c   Sampath, T Kuber ^c   Morton, Ronald A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b University of Ulsan   (South Korea)

^c CURIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; CANCER GRADING; CELL GROWTH; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER;

BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GROWTH FACTOR; TRANSFORMING GROWTH FACTORS;

EID: 0342657717     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.
2. Ide, H., Katoh, M., Sasaki, H., Yoshida, T., Aoki, K., Nawa, Y., Osada, Y., Sugimura, T., and Terada, M. Cloning of human bone morphogenetic protein type IB receptor (BMPR-IB) and its expression in prostate cancer in comparison with other BMPRs. Oncogene, 14: 1377-1382, 1997.
3. Autzen, P., Robson, C. N., Bjartell, A., Malcolm, A. J., Johnson, M. I., Neal, D. E., and Hamdy, F. C. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br. J. Cancer, 78: 1219-1223, 1998.
4. Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., and Wang, E. A. Novel regulators of hone formation: molecular clones and activities. Science (Washington DC), 242: 1528-1534, 1988.
5. Wozney, J. M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev., 32: 160-167, 1992.
6. Sampath, T. K., Maliakal, J. C., Hauschka, P. V., Jones, W. K., Sasak, H., Tucker, R. F., White, K. H., Coughlin, J. E., Tucker, M. M., and Pang, R. H. L. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteblast proliferation and differentiation in vitro. J. Biol. Chem., 267: 20352-20362, 1992.
7. Hogan, B. L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev., 10: 1580-1594, 1996.
8. Lind, M., Eriksen, E. F., and Bunger, C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone, 18: 53-57, 1996.
9. Paralkar, V. M., Weeks, B. S., Yu, Y. M., Kleinman, H. K., and Reddi, A. H. Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. J. Cell. Biol., 119: 1721-1728, 1992.
10. Massague, J., and Weis-Garcia, F. Serine/threonine kinase receptors: mediators of transforming growth factor β family signals. Cancer Surv., 27: 41-64, 1996.
11. Winnier, G., Blessing, M., Labosky, P. A., and Hogan, B. L. M. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev., 9: 2105-2116, 1995.
12. Luo, G., Hofman, C., Bronckers, A. L. J. J., Sohocki, M., Bradley, A., and Karsentry, G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev., 9: 2808-2820, 1995.
13. Yamashita, H., Ten-Dijke, P., Heldin, C-H., and Miyazono, K. Bone morphogenetic protein receptors. Bone, 19: 569-574, 1996.
14. Liu, F., Ventura, F., Doody, J., and Massague, J. Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to BMPs. Mol. Cell. Biol., 15: 3479-3486, 1995.
15. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Esterez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., and Miyazono, K. Introduction of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem., 269: 16985-16988, 1994.
16. Ide, H., Yoshida, T., Matsumoto, N., Aoki, K., Osada, Y., Sugimura, T., and Terada, M. Growth regulation of human prostate career cells by bone morphogenetic protein-2. Cancer Res., 57: 5022-5027, 1997.
17. Gleason, P. F., Mellinger, G., and the Veterans Administeration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58-64, 1974.
18. Yonemori, K., Imamura, T., Ishidou, Y., Okano, T., Matsunaga, S., Yoshida, H., Kato, M., Sampath, T. K., Miyazono, K., Ten Dijke, P., and Sakou, T. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament. Am. J. Pathol., 150: 1335-1347, 1997.
19. Yamada, N., Kato, M., Ten Dijke, P., Yamashita, H., Sampath, T. K., Heldin, C-H., Miyazono, K., and Funa, K. Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumors. Br. J. Cancer, 73: 624-629, 1996.
20. Nemeth, J. A., Sensibar, J. A., White, R. R., Zelner, D. J., Kim, I. Y., and Lee, C. The prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-β1. Prostate, 33: 64-71, 1997.
21. Kim, I. Y., Ahn, H-J., Zelner, D. J., Park, L., Sensibar, J. A., and Lee, C. Expression and localization of transforming growth factor-β receptors type I and type II in the rat ventral prostate during regression. Mol. Endocrinol., 10: 107-115, 1996.
22. Soda, H., Raymond, E., Shauna, S., Lawrence, R., Cerna, C., Gomez, L., Timony, G. A., Von Hoff, D. D., and Izerbicka, E. Antiproliferative effects of recombinant human bone morphogenetic protein 2 on human tumor colony-forming units. Anticancer Drugs, 9: 327-331, 1998.